Daymark Wealth Partners LLC Sells 12,791 Shares of Corteva, Inc. $CTVA

Daymark Wealth Partners LLC reduced its stake in shares of Corteva, Inc. (NYSE:CTVA) by 35.7% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 23,054 shares of the company’s stock after selling 12,791 shares during the quarter. Daymark Wealth Partners LLC’s holdings in Corteva were worth $1,545,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. Fox Run Management L.L.C. grew its holdings in Corteva by 5.1% during the third quarter. Fox Run Management L.L.C. now owns 3,361 shares of the company’s stock valued at $227,000 after purchasing an additional 164 shares during the period. IFG Advisory LLC raised its holdings in Corteva by 1.7% in the third quarter. IFG Advisory LLC now owns 9,764 shares of the company’s stock worth $660,000 after purchasing an additional 166 shares during the period. Kelleher Financial Advisors raised its holdings in Corteva by 3.8% in the third quarter. Kelleher Financial Advisors now owns 4,594 shares of the company’s stock worth $311,000 after purchasing an additional 170 shares during the period. Rosenberg Matthew Hamilton boosted its position in shares of Corteva by 6.1% during the fourth quarter. Rosenberg Matthew Hamilton now owns 2,969 shares of the company’s stock worth $199,000 after purchasing an additional 172 shares in the last quarter. Finally, United Community Bank grew its holdings in shares of Corteva by 10.5% in the 3rd quarter. United Community Bank now owns 1,849 shares of the company’s stock valued at $125,000 after buying an additional 176 shares during the period. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Trading Up 1.8%

Shares of NYSE:CTVA opened at $82.00 on Thursday. The firm has a market cap of $55.05 billion, a price-to-earnings ratio of 51.90, a PEG ratio of 2.75 and a beta of 0.72. Corteva, Inc. has a 12 month low of $53.40 and a 12 month high of $82.26. The company’s fifty day simple moving average is $75.76 and its 200 day simple moving average is $69.53. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last announced its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.22. The firm had revenue of $3.91 billion during the quarter, compared to analyst estimates of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The company’s revenue for the quarter was down 1.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, research analysts forecast that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 16th. Investors of record on Monday, March 2nd were issued a dividend of $0.18 per share. The ex-dividend date was Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is presently 45.57%.

Analyst Ratings Changes

CTVA has been the subject of a number of recent analyst reports. BNP Paribas Exane upped their price objective on shares of Corteva from $72.00 to $74.00 in a research report on Monday, March 9th. Royal Bank Of Canada lifted their target price on Corteva from $80.00 to $89.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. Zacks Research cut Corteva from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 20th. JPMorgan Chase & Co. downgraded Corteva from an “overweight” rating to a “neutral” rating and increased their price target for the stock from $75.00 to $77.00 in a report on Thursday, February 5th. Finally, The Goldman Sachs Group reaffirmed a “buy” rating and set a $88.00 price target on shares of Corteva in a research report on Thursday, February 5th. One analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat, Corteva presently has a consensus rating of “Moderate Buy” and a consensus price target of $82.90.

Insider Transactions at Corteva

In related news, insider Brian Titus sold 8,311 shares of Corteva stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the sale, the insider owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. This trade represents a 50.67% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.14% of the company’s stock.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.